Navigation Links
GeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.

ProductsGeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.
Company GeneChoice, Inc.
Item GeneChoice TEMPase II DNA Polymerase
Price $220.00
Description • Heat activated
• Eliminates nonspecific products due to inactivity at room temperature
• Excellent specificity allows extension through DNA regions which contain repeats and secondary structures
• Leaves an 'A' overhang

TEMPase II is a chemically modified form of GeneChoice DNA Polymerase that remains inactive at room temperature and works optimally in a distinctive buffer system.

TEMPase II is useful for performing automated hot start amplification due to its thermal activation at a temperature well above optimal annealing. The enzyme remains inactive until the time, temperature, and pH are optimal. During hot start, primers bind only to their specific target, and polymerase activity is directed exclusively to that target. As a result, only the region of interest is amplified, which increases sensitivity and yield while reducing non-specific background amplification.

Once the reaction reaches optimal annealing temperatures after a 15 minute activation step at 95C, the enzyme stays activated in the reaction.

Since the enzyme is chemically modified for hot start (no antibody), there is no material from animal sources, i.e., there is no possibility for biological contamination.

10X TEMPase II Reaction Buffer - Combination of (NH4)2S04 and KCl, 15 mM MgCl2, 1% Tween 20.
25 mM MgCl2 Solution - Supplied.
Info GeneChoice, Inc.GeneChoice, Inc.
7307 Governors Way
Frederick, MD 21703 USA

Call GeneChoice, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-772-8354
Customer Service: 866-636-2200
Fax Number: 301-620-0162
Web Site: http://www.genechoiceinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
2. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
3. GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.
4. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
5. T4 DNA Polymerase from Roche Applied Science
6. T4 DNA Polymerase from Roche Applied Science
7. Poly A Polymerase from Invitrogen
8. iTaq DNA Polymerase, 250 U from Bio-Rad
9. iTaq DNA Polymerase, 5,000 U from Bio-Rad
10. Taq DNA Polymerase, 500 U (2 x 250 U) without dNTP from Bioneer, Inc.
11. T4 DNA Polymerase from Invitrogen
... Resolution - Efficiently separates ... to 1000 bp. It ... PCR fragments, small DNA ... enzyme digestion, and double-stranded ...
... Anti-PRK2 MW 140kDa ... Immunogen Peptide spanning amino acids ... Purification immunoaffinity purified Quality ... RIPA lysates from HeLa cells. ...
MarrowMAX Bone Marrow Medium...
Histone H2A Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Detects ~14 kDa Histone H2A. It does not cross-react with other Histones. Reacts with human/mouse/rat. Performs w...
Biology Products:
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... Center today awarded 12 research grants, totaling nearly ... efforts. , The two-year grants of up to ... track the remediation of harmful algae blooms; assess ... plant invasions; study chromosomal damage in tree swallow ... , The grants were awarded to multidisciplinary teams ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
Breaking Biology News(10 mins):Keeping stem cells strong 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... A comprehensive system of vaccine development in the U.S. ... 99 percent in illness from ten vaccine-preventable diseases during ... taken for granted, however, as the vaccine system now ... a review article in the May/June issue of Health ...
... diseases (STDs) requires treatment of the sexual partners of ... men with antibiotics to give their partners is more ... partners, according to an article in the Sept. 1 ... with chlamydia or gonorrhea were more likely to see ...
... a cancer drug that can burrow into a tumor, ... anti-cancer toxins, all while leaving healthy cells unscathed. , ... that. , The dual-chamber, double-acting, drug-packing "nanocell" proved effective ... of cancers--melanoma and Lewis lung cancer--in mice. , The ...
Cached Biology News:Fragile US vaccine system needs improvement despite dramatic gains in health over past century 2Fragile US vaccine system needs improvement despite dramatic gains in health over past century 3New study: Sexually transmitted disease treatment can be effectively administered by sex partners 2New study: Sexually transmitted disease treatment can be effectively administered by sex partners 3MIT engineers an anti-cancer smart bomb 2
(Date:5/23/2013)... (PRWEB) May 23, 2013 Just released this ... executive coach and author Barbara Roche: “Commit to Confidence: ... , Filled with helpful tips and quotes from the fields ... leaders, and tangible exercises that readers can do on their ... to achieve their personal and professional goals. , ...
(Date:5/22/2013)... Washington, NY (PRWEB) May 22, 2013 ... comprehensive line of accessories for the mobile lifestyle, announces ... charge, sync, protect, and manage multiple iPad devices efficiently. ... award and the 2012 Good Design award, MultiCharger-X is ... the iPad, wherever it is deployed. , ...
(Date:5/22/2013)... , May 22, 2013   Oligomerix, Inc. ... of disease modifying therapeutics for Alzheimer,s disease (AD) ... of its Series B financing, which includes both ... that would represent approximately $2.8M in new investments ... investors supported the raise. Funding ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013 /PRNewswire/ ... regenerative medicine, presented new data generated in collaboration with ... leading health economics consultancy) demonstrating the significant healthcare resource ... venous leg ulcers (VLU) place upon the US healthcare ... which reveal annual costs of up to $15 billion ...
Breaking Biology Technology:iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4